Pandemic Darlings The pandemic economy, in original documents
Home Source documents Vaxart, Inc., Form 25, Notification of Removal From Listing and/or Registration Under Section 12(b) of the Securities Exchange Act of 1934

Vaxart, Inc., Form 25, Notification of Removal From Listing and/or Registration Under Section 12(b) of the Securities Exchange Act of 1934

Summary

This Form 25, a notification of removal from listing and registration under Section 12(b) of the Securities Exchange Act of 1934, names Vaxart, Inc. (Commission File Number 001-35285) as issuer and Nasdaq Stock Market LLC as the exchange, for its common stock. It lists the provisions of 17 CFR 240.12d2-2(a)(1) through (a)(4) and states that, pursuant to 17 CFR 240.12d2-2(b), the exchange has complied with its rules to strike the class of securities from listing and withdraw registration. Nasdaq certifies that it has reasonable grounds to believe it meets the requirements for filing, and the form is signed on its behalf by Aravind Menon, Hearings Advisor, and dated 2025-11-21.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

UNITED STATES | OMB APPROVAL OMB Number: 3235-0080 Expires: March 31, 2018 Estimated average burden hours per response: 1.7 | OMB APPROVAL | OMB Number: 3235-0080 Expires: March 31, 2018 Estimated average burden hours per response: 1.7 | OMB Number: | 3235-0080 | Expires: | March 31, 2018 | Estimated average burden | hours per response: | 1.7
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number | 001-35285
Issuer: Vaxart, Inc. Exchange: Nasdaq Stock Market LLC (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) Address: 290 Utah Ave, Suite 200 South San Francisco CALIFORNIA 94080 Telephone number: 650-550-3500 (Address, including zip code, and telephone number, including area code, of Issuer's
 principal executive offices) Common Stock (Description of class of securities) | Issuer: Vaxart, Inc. Exchange: Nasdaq Stock Market LLC | Issuer: | Vaxart, Inc. | Exchange: | Nasdaq Stock Market LLC | (Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered) | Address: 290 Utah Ave, Suite 200 South San Francisco CALIFORNIA 94080 Telephone number: 650-550-3500 | Address: | 290 Utah Ave, Suite 200 | South San Francisco | CALIFORNIA | 94080 | Telephone number: | 650-550-3500 | (Address, including zip code, and telephone number, including area code, of Issuer's
 principal executive offices) | Common Stock | (Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike
 the class of securities from listing and registration:
17 CFR 240.12d2-2(a)(1) 17 CFR 240.12d2-2(a)(2) 17 CFR 240.12d2-2(a)(3) 17 CFR 240.12d2-2(a)(4) Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1 Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange. | 17 CFR 240.12d2-2(a)(1) | 17 CFR 240.12d2-2(a)(2) | 17 CFR 240.12d2-2(a)(3) | 17 CFR 240.12d2-2(a)(4) | Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1 | Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it
 meets all of the requirements for filing the Form 25 and has caused this notification to be
 signed on its behalf by the undersigned duly authorized person.
2025-11-21 By Aravind Menon Hearings Advisor Date Name Title | 2025-11-21 | By | Aravind Menon | Hearings Advisor | Date | Name | Title
1 Form 25 and attached Notice will be considered compliance with the provisions of
 17 CFR 240.19d-1 as applicable. See General Instructions. | 1 | Form 25 and attached Notice will be considered compliance with the provisions of
 17 CFR 240.19d-1 as applicable. See General Instructions.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File
d05-19b.html
Size
10,239 bytes
SHA-256
4f8a7d4f546b05dee66394470ec8d95346c2e2a5cd41d280dbf730b6f406fcb8
Our copy
d05-19b.html
Original
www.sec.gov
Back to top